PTCA (n=630) | Medical treatment (n=610) | p Value | |
---|---|---|---|
ACE, angiotensin converting enzyme; PTCA, percutaneous transluminal coronary angioplasty. | |||
Statins | 329 (52%) | 230 (38%) | <0.001 |
Fibrates | 48 (8%) | 41 (7%) | NS |
Aspirin | 579 (92%) | 499 (82%) | <0.001 |
Other antiplatelet agents | 64 (10%) | 39 (6%) | <0.02 |
Oral anticoagulants | 28 (6%) | 77 (10%) | <0.01 |
β Blockers | 456 (72%) | 383 (63%) | <0.003 |
ACE inhibitors | 257 (41%) | 268 (44%) | NS |
Calcium antagonists | 148 (24%) | 200 (33%) | <0.001 |
Oral antidiabetic agents | 76 (12%) | 95 (16%) | NS |
Insulin | 21 (3%) | 36 (6%) | <0.05 |